1-[2-(3-Diethylamino-2-hydroxy-propoxy)-phenyl]-3-phenyl-propan-1-one

ID: ALA93496

PubChem CID: 2856987

Max Phase: Preclinical

Molecular Formula: C22H29NO3

Molecular Weight: 355.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: SJ000150489 | CHEMBL93496|1-{2-[3-(diethylamino)-2-hydroxypropoxy]phenyl}-3-phenylpropan-1-one|MLS000107538|1-(2-(3-(diethylamino)-2-hydroxypropoxy)phenyl)-3-phenylpropan-1-one|CBMicro_026350|SCHEMBL1331282|HMS2487J21|BDBM50134982|AKOS003377641|AKOS022066752|SMR000111904|BIM-0026533.P001|SJ000150489|1-[2-(3-Diethylamino-2-hydroxy-propoxy)-phenyl]-3-phenyl-propan-1-one|1-(2-(3-(diethylamino)-2-hydroxypropoxy)phenyl)-3-phenylpropan-1-one | 1-{2-[3-(diethylamino)-2-hydroxypropoxy]phenyl}-3-phenylprShow More

Canonical SMILES:  CCN(CC)CC(O)COc1ccccc1C(=O)CCc1ccccc1

Standard InChI:  InChI=1S/C22H29NO3/c1-3-23(4-2)16-19(24)17-26-22-13-9-8-12-20(22)21(25)15-14-18-10-6-5-7-11-18/h5-13,19,24H,3-4,14-17H2,1-2H3

Standard InChI Key:  XBYIRYDJOVXGAL-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 27  0  0  0  0  0  0  0  0999 V2000
   11.0194   -7.2666    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0182   -8.0940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7331   -8.5069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4495   -8.0935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4466   -7.2630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7313   -6.8539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1596   -6.8478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8756   -7.2576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1564   -6.0228    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.5885   -6.8424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3045   -7.2522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3045   -8.0761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0197   -8.4858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7336   -8.0706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7278   -7.2413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0120   -6.8353    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1646   -8.5049    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.1659   -9.3299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8810   -9.7413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8823  -10.5663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5949   -9.3277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.5974  -10.9777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.5987  -11.8027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3139  -12.2140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3113  -10.5640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0264  -10.9754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  1  0
  1  2  2  0
 13 14  2  0
  5  7  1  0
 14 15  1  0
  3  4  2  0
 15 16  2  0
 16 11  1  0
  7  8  1  0
  4 17  1  0
 17 18  1  0
  7  9  2  0
 18 19  1  0
  4  5  1  0
 19 20  1  0
  8 10  1  0
 19 21  1  0
  2  3  1  0
 20 22  1  0
 10 11  1  0
 22 23  1  0
  5  6  2  0
 23 24  1  0
 11 12  2  0
 22 25  1  0
  6  1  1  0
 25 26  1  0
M  END

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM/VCR-1000 (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB1 Tchem P-glycoprotein 1 (14716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TSHR Tclin Thyroid stimulating hormone receptor (29986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GMNN Tbio Geminin (128009 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GLP1R Tclin Glucagon-like peptide 1 receptor (111429 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TGR Thioredoxin glutathione reductase (28579 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rorc Nuclear receptor ROR-gamma (89407 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 355.48Molecular Weight (Monoisotopic): 355.2147AlogP: 3.58#Rotatable Bonds: 11
Polar Surface Area: 49.77Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.56CX LogP: 3.75CX LogD: 2.57
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.63Np Likeness Score: -0.68

References

1. Chiba P, Burghofer S, Richter E, Tell B, Moser A, Ecker G..  (1995)  Synthesis, pharmacologic activity, and structure-activity relationships of a series of propafenone-related modulators of multidrug resistance.,  38  (14): [PMID:7629817] [10.1021/jm00014a031]
2. Ecker G, Chiba P, Hitzler M, Schmid D, Visser K, Cordes HP, Csöllei J, Seydel JK, Schaper KJ..  (1996)  Structure-activity relationship studies on benzofuran analogs of propafenone-type modulators of tumor cell multidrug resistance.,  39  (24): [PMID:8941391] [10.1021/jm960384x]
3. Fleischer R, Wiese M..  (2003)  Three-dimensional quantitative structure-activity relationship analysis of propafenone-type multidrug resistance modulators: influence of variable selection on test set predictivity.,  46  (23): [PMID:14584949] [10.1021/jm030876r]
4. Kaiser D, Terfloth L, Kopp S, Schulz J, de Laet R, Chiba P, Ecker GF, Gasteiger J..  (2007)  Self-organizing maps for identification of new inhibitors of P-glycoprotein.,  50  (7): [PMID:17352460] [10.1021/jm060604z]
5. Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F, Jiménez-Díaz MB, Martinez MS, Wilson EB, Tripathi AK, Gut J, Sharlow ER, Bathurst I, El Mazouni F, Fowble JW, Forquer I, McGinley PL, Castro S, Angulo-Barturen I, Ferrer S, Rosenthal PJ, Derisi JL, Sullivan DJ, Lazo JS, Roos DS, Riscoe MK, Phillips MA, Rathod PK, Van Voorhis WC, Avery VM, Guy RK..  (2010)  Chemical genetics of Plasmodium falciparum.,  465  (7296): [PMID:20485428] [10.1038/nature09099]
6. PubChem BioAssay data set,